COLUMBIA, Md. and SAN MATEO, Calif., Jan 05, 2007 /PRNewswire-FirstCall via COMTEX/ -- DHA omega-3 innovator Martek Biosciences and NutraBella announced today that Bellybar(TM), an all natural line of snack bars for pregnant and breastfeeding women, has introduced Burstin' Chocolate, featuring Martek's life'sDHA(TM). Designed to meet the nutritional needs of women before, during and after pregnancy, the new bar includes 100 mg of life'sDHA(TM), a vegetarian form of DHA omega-3. DHA is a fatty acid important for optimal brain, eye, and nervous system development in infants and may play a role in maternal well- being. This "on-the-go" snack will provide health-conscious women with healthy calories, vitamins (such as folic acid and iron) and minerals that complement their other sources of nutrition. At a 1.59 oz. (45 gm) size, the Burstin' Chocolate bar is a sensible, healthy treat. The snack bars are currently available at select Whole Foods Markets, Babies-R-Us, Mimi Maternity, Motherhood Maternity, Wegmans, Meijer, Hannaford, HEB and other select retailers around the United States.
"In developing Bellybar(TM), our goal has been to constantly deliver the best possible products for women pre-conception, during pregnancy and while nursing. We are so pleased to be launching a product that provides life'sDHA(TM), along with other key vitamins and minerals, to women during this important time while maintaining the exceptional taste that women expect from Bellybar," said Meredith Lincoln, Co-Founder of NutraBella.
"We are excited to be working with NutraBella on this nutritional product which is being marketed to health conscious women before, during and after pregnancy. Bellybar(TM), already enjoyed by expecting moms, is now providing these women with the opportunity to get DHA omega-3 from a safe, great-tasting source, along with other key nutrients for health," said Steve Dubin, Martek's CEO.
DHA omega-3 is a long chain omega-3 fatty acid that serves as a primary building block for the brain and the eye and supports brain, eye and cardiovascular health throughout life. There is a large and growing body of scientific evidence demonstrating that people of all ages, from infants to aging adults, benefit from an adequate supply of DHA omega-3 in the diet. Several recent scientific reviews have noted the importance of DHA omega-3 in proper brain and eye development and function, and there are large clinical studies underway to evaluate its role in decreasing the prevalence of certain neurological disorders. Yet despite its importance, Americans have among the lowest dietary intakes of DHA omega-3 in the world.
Martek's life'sDHA(TM) is unique in the market because it is derived from a sustainable and vegetarian source. Made from microalgae under tightly controlled manufacturing conditions, life'sDHA(TM) is free of oceanic contaminants that may be present in certain fish or fish oils. Microalgae are the only vegetarian source of DHA omega-3, the key omega-3 for brain development and function.
NutraBella was founded in 2004 to improve the nutritional well-being of today's active women by providing great tasting, nutrient-enriched products that are both convenient and delicious. Created by Meredith Lincoln and Leslie Sagalowicz, the all-natural food products company promotes good nutrition and a better way to get the critical nutrients needed before, during and after pregnancy. For more information, visit http://www.BellyProducts.com.
Martek Biosciences Corporation (MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a sustainable and vegetarian source of DHA omega-3, for use in foods, beverages, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/.
Sections of this release contain forward-looking statements concerning, among other things, expectations regarding NutraBella product launches and widespread use of life'sDHA(TM). These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the Company's filings with the Securities and Exchange Commission, including, but not limited to, the Company's Form 10-Q for the fiscal quarter ended July 31, 2006 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.